ReviewMediastinum (Hong Kong, China)2025
Mediastinal tumors: why, when, and how to biopsy?
Review in Mediastinum (Hong Kong, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Mediastinal Ectopic Pancreas Mimicking Lymphoma with Discordant Histology and Flow Cytometry: A Diagnostic Challenge.Diagnostics (Basel, Switzerland) · 2026Article
- Preoperative and anesthetic management of high-risk cardiovascular complications of mediastinal masses: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Confronting Upside-Down Video Assisted Thoracic Surgery for Posterior Mediastinal Müllerian Duct Cysts.Cureus · 2026Article
- Classification of mediastinal compartments: is separation of the superior mediastinum crucial?-a clinical practice review.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The finding of a mediastinal mass often poses a diagnostic challenge for clinicians. A correct diagnosis on the nature of a mediastinal tumor is important prior to initiating any treatment. Therefore, good knowledge is needed on mediastinal anatomy and its different compartments as well as on the differential diagnosis of a wide variety of benign and malignant mediastinal lesions. A complete history of the symptoms and a full clinical examination together with imaging and laboratory tests can guide the clinician towards a final diagnosis at presentation. Pretreatment tissue biopsy of a mediastinal tumor is not always required in case the clinical diagnosis is highly probable based on the above findings and when the tumor looks well encapsulated and of non-invasive nature amenable to upfront complete surgical resection as judged by the thoracic surgeon. Tissue diagnosis is recommended for a clinically and radiographically for cancer suspected, locally advanced or unresectable mediastinal mass in order to confirm the diagnosis and to guide induction therapy or definitive systemic treatment. An ultrasound or computed tomography (CT)-guided core needle biopsy may result in sufficient tissue for definitive cytopathological diagnosis. Otherwise, a minimally invasive procedure by video-assisted thoracoscopy (VATS) or robot-assisted thoracoscopy (RATS) or occasionally an open surgical biopsy may be necessary to obtain more tissue for pathological examination and molecular testing. Depending on the location of the mediastinal mass in any of the mediastinal compartments, various surgical approaches can be chosen to biopsy. A frozen section is helpful to check the quality of the biopsy but is less effective for a precise diagnosis. The definitive pathological report needs to be awaited prior to initiating any treatment except in case of a life-threatening condition such as critical airway compression or superior vena cava syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.